Effects of the neuropeptide S receptor antagonist RTI-118 on abuse-related facilitation of intracranial self-stimulation produced by cocaine and methylenedioxypyrovalerone (MDPV) in rats

European Journal of Pharmacology

Volumn 743, Issue , 2014, Pages 98-105

  Bonano, Julie S ^a   Runyon, Scott P ^b   Hassler, Carla ^b   Glennon, Richard A ^a   Stevens Negus, S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Cocaine; Intracranial self stimulation; Methylenedioxypyrovalerone; Neuropeptide S; RTI 118

Indexed keywords

3 OXO 1,1 DIPHENYL N (2 [PIPERIDIN 1 YL)ETHYL]TETRAHYDRO 1H OXAZOLO[3,4 A]PYRAZINE 7(3H) CARBOXAMIDE; COCAINE; METHYLENEDIOXYPYROVALERONE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR ANTAGONIST; PYROVALERONE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 3,4-METHYLENEDIOXYPYROVALERONE; 3-(4'-CHLOROPHENYL)-2-(5'-PHENYL-1',3',4'-OXADIAZOL-2'-YL)TROPANE; KAPPA OPIATE RECEPTOR; NEUROPEPTIDE; PYRROLIDINE DERIVATIVE; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; ELECTRODE; HUMAN; HUMAN CELL; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; RAT; SELF STIMULATION; SPRAGUE DAWLEY RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHO CELL LINE; COCAINE-RELATED DISORDERS; CRICETULUS; DRUG EFFECTS; DRUG SELF ADMINISTRATION; HEK293 CELL LINE; METABOLISM; PROCEDURES; REINFORCEMENT; SUBSTANCE-RELATED DISORDERS;

ANIMALS; BENZODIOXOLES; CHO CELLS; COCAINE; COCAINE-RELATED DISORDERS; CRICETULUS; HEK293 CELLS; HUMANS; MALE; MEDIAL FOREBRAIN BUNDLE; NEUROPEPTIDES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; RECEPTORS, OPIOID, KAPPA; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SELF STIMULATION; SUBSTANCE-RELATED DISORDERS; TROPANES;

EID: 84919340267     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.09.006     Document Type: Article

References (37)

1. C.T. Bauer, M.L. Banks, B.E. Blough, and S.S. Negus Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats Br. J. Pharmacol. 168 2013 850 862
2. C.T. Bauer, M.L. Banks, and S.S. Negus The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats Psychopharmacology 231 2014 2461 2470
3. M.H. Baumann, J.S. Partilla, and K.R. Lehner Psychoactive "bath salts": not so soothing Eur. J. Pharmacol. 698 2013 1 5
4. M.H. Baumann, J.S. Partilla, K.R. Lehner, E.B. Thorndike, A.F. Hoffman, M. Holy, R.B. Rothman, S.R. Goldberg, C.R. Lupica, H.H. Sitte, S.D. Brandt, S.R. Tella, N.V. Cozzi, and C.W. Schindler Powerful cocaine-like actions of 3,4-Methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products Neuropsychopharmacology 38 2012 552 562
5. J. Bonano, R.A. Glennon, L. De Felice, M.L. Banks, and S.S. Negus Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats Psychopharmacology 231 2013 199 207
6. K. Cameron, R. Kolanos, R. Verkariya, L. De Felice, and R.A. Glennon Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter Psychopharmacology 227 2013 493 499
7. W.A. Carlezon Jr., and E.H. Chartoff Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation Nat. Protoc. 2 2007 2987 2995
8. E.H. Chartoff, D. Potter, D. Damez-Werno, B.M. Cohen, and W.A. Carlezon Jr. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats Neuropsychopharmacology 33 2008 2676 2687
9. C. Chavkin The therapeutic potential of kappa-opioids for treatment of pain and addiction Neuropsychopharmacology 36 2011 369 370
10. D. Dal Ben, I. Antonini, M. Buccioni, C. Lambertucci, G. Marucci, A. Thomas, R. Volpini, and G. Cristalli Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery Chem. Med. Chem. 6 2011 1163 1171
11. L.J. De Felice, R.A. Glennon, and S.S. Negus Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology Life Sci. 97 2014 20 26
12. R.A. Gregg, and S.M. Rawls Behavioral pharmacology of designer cathinones: a review of the preclinical literature Life Sci. 97 2014 27 30
13. R. Guerrini, S. Salvadori, A. Rizzi, D. Regoli, and G. Calo Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor Med. Res. Rev. 30 2010 751 777
14. C. Hassler, Y. Zhang, B. Gilmour, T. Graf, T. Fennell, R. Snyder, J.R. Deschamps, R.K. Reinscheid, C. Garau, and S.P. Runyon Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation ACS Chem. Neurosci. 5 2014 731 744
15. M. Kallupi, N. Cannella, D. Economidou, M. Ubaldi, B. Ruggeri, F. Weiss, M. Massi, J. Marugan, M. Heilig, P. Bonnavion, L. de Lecea, and R. Ciccocioppo Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system Proc. Natl. Acad. Sci. USA 107 2010 19567 19572
16. M. Kallupi, G. de Guglielmo, N. Cannella, H.W. Li, G. Calo, R. Guerrini, M. Ubaldi, J.J. Renger, V.N. Uebele, and R. Ciccocioppo Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat Psychopharmacology 226 2013 347 355
17. S.K. Leonard, and R.H. Ring Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system Neuroscience 172 2011 153 163
18. N.K. Mello, and S.S. Negus Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys J. Pharmacol. Exp. Ther. 286 1998 812 824
19. N.K. Mello, and S.S. Negus Interactions between kappa opioid agonists and cocaine. Preclinical studies Ann. N. Y. Acad. Sci. 909 2000 104 132
20. National Research Council Guide for the Care and Use of Laboratory Animals 8th edition 2011 National Academy Press Washington DC
21. S.S. Negus, N.K. Mello, P.S. Portoghese, and C.E. Lin Effects of kappa opioids on cocaine self-administration by rhesus monkeys J. Pharmacol. Exp. Ther. 282 1997 44 55
22. S.S. Negus, and L.L. Miller Intracranial self-stimulation (ICSS) to evaluate abuse potential of drugs Pharmacol. Rev. 66 2014 869 917
23. S.S. Negus, R. O'Connell, E. Morrissey, K. Cheng, and K.C. Rice Effects of peripherally restricted kappa opioid receptor agonists on pain-related stimulation and depression of behavior in rats J. Pharmacol. Exp. Ther. 340 2012 501 509
24. C. Paneda, S. Huitron-Resendiz, L.M. Frago, J.A. Chowen, R. Picetti, L. de Lecea, and A.J. Roberts Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice J. Neurosci. 29 2009 4155 4161
25. M. Rosenberg, F.I. Carroll, and S.S. Negus Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats J Pain 14 2013 246 259
26. C.D. Schmoutz, Y. Zhang, S.P. Runyon, and N.E. Goeders Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats Pharmacol. Biochem. Behav. 103 2012 332 337
27. T.S. Shippenberg, V.I. Chefer, A. Zapata, and C.A. Heidbreder Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems Ann. N. Y. Acad. Sci. 937 2001 50 73
28. H.A. Tejeda, T.S. Shippenberg, and R. Henriksson The dynorphin/kappa-opioid receptor system and its role in psychiatric disorders Cell. Mol. Life Sci. 69 2012 857 896
29. M.S. Todtenkopf, J.F. Marcus, P.S. Portoghese, and W.A. Carlezon Jr. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats Psychopharmacology 172 2004 463 470
30. H.C. Tomasiewicz, M.S. Todtenkopf, E.H. Chartoff, B.M. Cohen, and W.A. Carlezon Jr. The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward Biol. Psychiatry 64 2008 982 988
31. S. Vlachou, and A. Markou Intracranial self-stimulation M.C. Olmstead, Animal Models of Drug Addiction 2011 Humana Press New York 3 56
32. S.L. Walsh, B. Geter-Douglas, E.C. Strain, and G.E. Bigelow Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans J. Pharmacol. Exp. Ther. 299 2001 147 158
33. L.R. Watterson, P.R. Kufahl, N.E. Nemirovsky, K. Sewalia, M. Grabenauer, B.F. Thomas, J.A. Marusich, S. Wegner, and M.F. Olive Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV) Addict. Biol 2012
34. S. Wee, and G.F. Koob The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse Psychopharmacology 210 2010 121 135
35. Y.L. Xu, C.M. Gall, V.R. Jackson, O. Civelli, and R.K. Reinscheid Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain J. Comp. Neurol. 500 2007 84 102
36. Y.L. Xu, R.K. Reinscheid, S. Huitron-Resendiz, S.D. Clark, Z. Wang, S.H. Lin, F.A. Brucher, J. Zeng, N.K. Ly, S.J. Henriksen, L. de Lecea, and O. Civelli Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects Neuron 43 2004 487 497
37. Y. Zhang, B.P. Gilmour, H.A. Navarro, and S.P. Runyon Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for neuropeptide S antagonist activity Bioorg. Med. Chem. Lett. 18 2008 4064 4067